The present invention provides a novel hydroxyquinoxaline carboxamide derivative that is useful for preventing and/or treating blood coagulation disorders. A compound represented by formula (i), or a pharmacologically acceptable salt thereof:
wherein, each of R
1
and R
2
independently represents a group such as a hydrogen atom or a halogen atom; R
3
represents a group such as a hydrogen atom; each of R
4
and R
5
independently represents a group such as a hydrogen atom, a halogen atom or a C
1-4
alkyl group; each of R
6
and R
7
independently represents a hydrogen atom or a C
1-4
alkyl group; X represents a group such as a C
3-10
cycloalkyl group, C
6-10
aryl group or a 5- to 10-membered heterocyclic group, which may be substituted with substituent(s) selected from substituent group α; Y represents a group such as —CO—, —O— or —NRa—, and Ra represents a group such as a hydrogen atom or a C
1-4
alkyl group.